SUBSCRIBE
Search JIM Advanced Search

Journal of Chinese Integrative Medicine ›› 2008, Vol. 6 ›› Issue (1): 25-31.doi: 10.3736/jcim20080106

• Original Clinical Research • Previous Articles     Next Articles

A randomized, controlled, double-blind trial of Huannao Yicong capsule in senile patients with mild cognitive impairment

Hao Li(), Ming-jiang Yao, Wen-ming Zhao, Jie Guan, Lin-lin Cai, Ling Cui   

  1. Department of Geriatrics, China Academy of Chinese Medical Sciences, Beijing 100091, China
  • Online:2008-01-20 Published:2008-01-15
  • Contact: LI Hao E-mail:xyhplihao@vip.sohu.com

RichHTML

2

PDF (PC)

51

Like

Objective:To observe the effect and explore the mechanism of Huannao Yicong capsule in treating senile patients with mild cognitive impairment (MCI).

Methods:The investigational drugs were packed by blind method. A randomized, double-blind and controlled trial was conducted on ninety senile patients with MCI. Other forty-five senile healthy persons were recruited to the healthy control group. The ninety senile patients were randomly divided into the Huannao Yicong capsule-treated group (45 patients administered with three Huannao Yicong capsules and two aniracetam capsule analogues) and aniracetam-treated group (45 patients treated with two aniracetam capsules and three Huannao Yicong capsule analogues). Patients in the two groups were treated three times daily for 16 weeks. Memory, traditional Chinese medicine syndrome, cerebral blood flow, free radicals and inflammatory mediators, such as superoxide dismutase (SOD), malondialdehyde (MDA),acetylcholinesterase (AchE), interleukin-la (IL-la) and interleukin-6 (IL-6) were determined before and after the treatment. Blood lipids, including triglyceride (TG), total cholesterol (TC), low density lipoprotein cholesterol (LDL-C), high density lipoprotein cholesterol (HDL-C), apolipoprotein A-l (ApoA-1) and apolipoprotein B-100 (ApoB-100), were detected before and after the treatment. The safety indexes, such as routine tests of blood and urine, hepatic and renal function tests and electrocardiogram (ECG) were taken before and after the treatment.

Results:Index score of clinical memory scale in senile healthy people was significantly higher than that in MCI patients before treatment (P<0. 01), and the content of AchE, IL-la and IL-6 was obviously lower (P<0.01, P<0.05), the activity of SOD was higher (P<0.05). No significant difference was found in direction memory of clinical memory scale between the two treatment groups. Other index scores of clinical memory scale and traditional Chinese medicine syndrome in patients of Huannao Yicong capsule-treated group were significantly improved as compared with those of the aniracetam-treated group (P<0.05, P<0.01). The blood flow parameters of anterior cerebral artery, posterior cerebral artery and resistant index in patients of Huannao Yicong capsule-treated group were increased significantly (P<0.01, P<0.05). Huannao Yicong capsule could significantly increase the activity of serum SOD and decrease the content of AchE, IL-la and IL-6 (P<0.01, P<0.05),better than aniracetam. Furthermore, Huannao Yicong capsule could significantly improve the blood lipid, such as the level of TG, LDL-C, HDL-C, ApoA-1 and ApoB-100 (P<0. 01, P<0.05), and better than aniracetam (P<0.01, P<0.05). No significant changes were found after treatment in safety indexes, such as routine tests of blood and urine, hepatic and renal function tests and ECG.

Conclusion:Huannao Yicong capsule has better therapeutic effect than aniracetam capsule in treating senile mild cognitive impairment.

Key words: herbal preparations: mild cognitive impairment, randomized controlled trial, double-blinded method, traditional Chinese medicine

CLC Number: 

  • R592

Table 1

Index score of clinical memory scale in senile healthy people and MCI patients before treatment (?x±s)"

Group n Directivity Association Image Figure Manikin Memory
Healthy 45 17.91±5.77 18.97±1.17 21.77±4.88 24.96±4.33 24.88±5.96 108.11±5.67
MCI 90 9.98±4.11** 12.07±5.01** 15.47±4.47** 18.33±5.01** 17.31±4.09** 77.89±7.61**

Table 2

Serum SOD, MDA, AchE, IL-1α and IL-6 in senile healthy people and MCI patients before treatment (?x±s)"

Group n SOD (kU/L) MDA (μmol/L) AchE mmol/L) IL-1α (ng/L) IL-6 (ng/L)
Healthy 45 119.74±17.55 4.05±0.47 34.88±6.63 0.488±0.32 2.87±1.49
MCI 90 91.47±15.42* 5.77±0.91* 49.09±7.01** 0.696±0.51** 3.84±2.09*

Table 3

Effect of Huannao Yicong capsule on index score of clinical memory scale in senile MCI patients (?x±s)"

Group n Directivity Association Image Figure Manikin Memory
Huannao Yicong capsule-treated
Before treatment 44 11.01±2.71 12.11±4.19 17.35±4.46 18.99±5.00 18.07±5.70 74.19±7.99
After treatment 44 17.32±4.71** 15.66±5.01**△△ 20.99±6.07*△△ 22.66±5.47*△△ 22.66±5.47**△△ 96.41±10.77**△△
Aniracetam-treated
Before treatment 43 11.70±2.07 11.96±4.37 16.99±3.47 19.89±6.46 18.88±6.17 75.02±7.84
After treatment 43 16.01±3.07** 14.88±4.96* 18.87±4.01 22.86±6.06 21.01±4.45 93.11±10.17**

Table 4

Effect of Huannao Yicong capsule on TCD test results in senile MCI patients (?x±s)"

Group n Middle cerebral artery Anterior cerebral artery Posterior cerebral artery
Vmean (cm/s) RI Vmean (cm/s) RI Vmean (cm/s) RI
Huannao Yicong capsule-treated
Before treatment 44 46.1±10.7 0.53±0.11 42.1±11.2 0.59±0.12 45.5±13.7 0.56±0.15
After treatment 44 49.3±11.2△ 0.39±0.24**△△ 59.3±12.7*△△ 0.41±0.09**△△ 53.7±14.3*△△ 0.46±0.13**△△
Aniracetam-treated
Before treatment 43 45.6±12.1 0.65±0.21 43.5±12.5 0.57±0.06 44.8±11.7 0.51±0.09
After treatment 43 47.3±13.1 0.52±0.11 48.6±14.2 0.47±0.11 48.6±13.7 0.47±0.15

Table 5

Effect of Huannao Yicong capsule on SOD, MDA, AchE, IL-1a and IL-6 in senile MCI patients (?x±s)"

Group n SOD (kU/L) MDA (μmol/L) AchE (mmol/L) IL-1α (ng/L) IL-6 (ng/L)
Huannao Yicong capsule-treated
Before treatment 44 92.09±14.11 5.25±0.55 50.11±8.17 0.715±0.37 3.88±1.96
After treatment 44 109.71±16.20**△△ 3.90±0.81** 43.13±9.02**△△ 0.531±0.29*△△ 2.17±0.67**△△
Aniracetam-treated
Before treatment 43 91.15±12.77 5.91±0.32 48.92±7.15 0.698±0.48 3.91±0.99
After treatment 43 100.9±15.67* 4.19±0.71** 44.05±8.01* 0.571±0.38 3.39±1.01

Table 6

Effect of Huannao Yicong capsule on blood lipids in senile MCI patiets (?x±s)"

Group n TG (mmol/L) TC (mmol/L) LDL-C (mmol/L) HDL-C (mmol/L) ApoA-1 (g/L) ApoB-100 (g/L)
Huannao Yicong capsule-treated
Before treatment 44 1.76±0.78 5.31±0.69 2.71±0.61 1.07±0.19 1.32±0.33 0.96±0.18
After treatment 44 1.39±0.61*△△ 5.22±0.71 1.98±0.74**△△ 1.21±0.16*△ 1.49±0.15*△ 0.76±0.21**△△
Aniracetam-treated
Before treatment 43 1.70±0.69 5.23±0.70 2.64±0.59 1.20±0.16 1.35±0.18 0.92±0.17
After treatment 43 1.69±0.71 5.22±0.69 2.59±0.48 1.11±0.18 1.44±0.20 0.81±0.21
[1] Wen HB , Zhou HB. Changes of cerebral blood flow in patients with mild cognitive impairment. Zhongguo Lin Chuang Kang Fu. 2005; 9(37):6-7. Chinese with abstract in English.
doi: 10.3321/j.issn:1673-8225.2005.37.005
闻红斌, 周宏斌 . 轻度认知障碍患者的脑血流变化. 中国临床康复. 2005; 9(37):6-7.
doi: 10.3321/j.issn:1673-8225.2005.37.005
[2] American Psychiatric Association . Diagnostic and statistical manual of mental disorders (DSM-JY). 4th ed. Washington: American Psychiatric Association. 1994: 143-147.
[3] Petersen RC, Smith GE, Waring SC , et al. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol. 1999; 56(3):303-308.
doi: 10.1001/archneur.56.3.303
[4] Reisberg B , Ferris SH, de Leon MJ, et al. The Global Deterioration Scale for the assessment of primary degenerative dementia. Am J Psychiatry. 1982; 139(9):1136-1139.
[5] Hughes CP, Berg L, Danziger WL , et al. A new clinical scale for the staging of dementia. Br J Psychiatry. 1982; 140:566-572.
doi: 10.1192/bjp.140.6.566 pmid: 7104545
[6] Folstein MF, Folstein SE , McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.[J] Psychiatr Res. 1975; 12(3):189-198.
doi: 10.1016/0022-3956(75)90026-6
[7] Clinical Memory Scale Editing Cooperation Group. Handbook of clinical memory scale. Beijing: Institute of Psychology, Chinese Academy of Sciences. 1996: 27-35. Chinese.
’’临床记忆量表’’编制协作组. 临床记忆量表手册.北京:中国科学院心理研究所. 1996: 27-35.
[8] Zheng XY. The clinical research principle of new traditional Chinese medicine. Beijing: China Medical- Pharmaceutical Science and Technology Publishing House. 2002: 92-96. Chinese.
郑筱萸 . 中药新药临床研究指导原则.北京: 中国医药科技出版社. 2002: 92-96.
[9] Panza F, Capurso C, DIntrono A , et al. Mild cognitive impairment : risk of Alzheimer disease and rate of cognitive decline. Neurology. 2007; 68(12):964-965.
doi: 10.1212/01.wnl.0000259691.26674.d3
[10] Gao P, Qin SS, Liu YH , et al. Study on the correlation between cognitive functions and regional blood flow in Alzheimer disease and mild cognitive impairment. Zhongguo Shen Jing Mian Yi Xue He Shen Jing Bing Xue Za Zhi. 2006; 13(4):205-208. Chinese with abstract in English.
doi: 10.3969/j.issn.1006-2963.2006.04.003
髙平, 秦绍森, 刘银红 , 等. Alzheimer病和轻度认知功能障碍患者认知功能与局部脑血流灌注的相关性研究.中国神经免疫学和神经病学杂志. 2006; 13(4):205-208.
doi: 10.3969/j.issn.1006-2963.2006.04.003
[11] Fu H, Wang XM, Liu GX, et al. Study on relationship between mild cognitive impairment and oxygen free radical metabolism, acetylcholinesterase. Zhongguo Lao Nian Xue Za zhi. 2004; 24(1):17-18. Chinese with abstract in English.
doi: 10.3969/j.issn.1005-9202.2004.01.008
富宏, 王学美, 刘庚信 , 等. 轻度认知障碍与氧自由基代谢和胆碱酯酶相关性的研究.中国老年学杂志.2004; 24(1):17-18
doi: 10.3969/j.issn.1005-9202.2004.01.008
[12] Weisman D, Hakimian E, Ho GJ . Interleukins, inflammation, and mechanisms of Alzheimer's disease. Vitam Horm. 2006; 74:505-530.
doi: 10.1016/S0083-6729(06)74020-1
[13] Ma LH, Dong WQ , Lin GZ. Metabolism of serum lipids in elder patients with mild cognitive impairment. Xin Nao Xue Guan Bing Fang Zhi. 2005; 5(6):28-29. Chinese.
doi: 10.3969/j.issn.1009-816X.2005.06.011
马立华, 董万青, 林桂珍 . 轻度认知障碍患者血脂水平的关系.心脑血管病防治. 2005; 5(6):28-29.
doi: 10.3969/j.issn.1009-816X.2005.06.011
[1] Sherman Gu, Arthur Yin Fan. Controversial conclusions from two randomized controlled trials for acupuncture's effects on polycystic ovary syndrome or in vitro fertilization support. Journal of Integrative Medicine, 2020, 18(2): 89-91.
[2] Xue-qing Yu, Shu-guang Yang, Yang Xie, Jian-sheng Li. Traditional Chinese medicine in the treatment of idiopathic pulmonary fibrosis based on syndrome differentiation: Study protocol of exploratory trial. Journal of Integrative Medicine, 2020, 18(2): 163-168.
[3] Chang-quan Ling. Traditional Chinese medicine is a resource for drug discovery against 2019 novel coronavirus (SARS-CoV-2). Journal of Integrative Medicine, 2020, 18(2): 87-88.
[4] Gerli E.G. Herr, Fábio Goulart da Silva, Francisco José Cidral-Filho, Fabricia Petronilho, Lucinéia Gainski Danielski, Mariana Pereira de Souza Goldim, Afonso Shiguemi Inoue Salgado, Franciane Bobinski, Daniel Fernandes Martins, Eliane R. Winkelmann. Effects of the use of bioceramic wraps in patients with lower limb venous ulcers: A randomized double-blind placebo-controlled trial. Journal of Integrative Medicine, 2020, 18(1): 27-.
[5] Wen Qiang Lee, Jeremy Teoh, Pei Zheng Kenneth Lee, Zhi Xiong Gerard Low, Xueling Sim, Foong Fong Mary Chong, Norbert Ludwig Wagner. Factors influencing communication of traditional Chinese medicine use between patients and doctors: a multisite cross-sectional study. Journal of Integrative Medicine, 2019, 17(6): 396-403.
[6] Mikhail Teppone. Medicine has always been “Modern” and “Scientific” from ancient times to the present day. Journal of Integrative Medicine, 2019, 17(4): 229-237.
[7] Charles Dalcanale Tesser, Ari Ojeda Ocampo Moré, Melissa Costa Santos, Emiliana Domingues Cunha da Silva, Fátima Terezinha Pelachini Farias, Lúcio José Botelho. Auriculotherapy in primary health care: A large-scale educational experience in Brazil. Journal of Integrative Medicine, 2019, 17(4): 302-309.
[8] Ya-ru Huangfu, Wei Peng, Bao-jun Guo, Zhi-fu Shen, Li Li, Shi-wei, Liu, Hui Zheng, You-ping Hu. Effects of acupuncture in treating insomnia due to spleen-stomach disharmony syndrome and its influence on intestinal microbiome: Study protocol for a randomized controlled trial. Journal of Integrative Medicine, 2019, 17(3): 161-167.
[9] Pádraic J.Dunne, Julie Lynch, Lucia Prihodova, Caoimhe O'Leary, Atiyeh Ghoreyshi, Sharee A. Basdeo, Donal J.Cox, Rachel Breen, Ali Sheikhi, Áine Carroll, Cathal Walsh, Geraldine McMahon, Barry White. Burnout in the emergency department: Randomized controlled trial of an attention-based training program. Journal of Integrative Medicine, 2019, 17(3): 173-180.
[10] Xin-yu Yue, Zhuo-qi Feng, Xi-yi Yu, Jia-min Hu, Xiao-Jing He, Shi Shu. Fire-needle acupuncture for upper limb spastic paralysis after stroke: Study protocol for a randomized controlled trial. Journal of Integrative Medicine, 2019, 17(3): 167-172.
[11] Rachael Farrington, Ian F.Musgrave, Roger W.Byard. Evidence for the efficacy and safety of herbal weight loss preparations. Journal of Integrative Medicine, 2019, 17(2): 87-92.
[12] Fung-Kei Cheng. An overview of the contribution of acupuncture to thyroid disorders. Journal of Integrative Medicine, 2018, 16(6): 375-383.
[13] J.M. Oliver-Baxter, H.S. Whitford, D.A. Turnbull, M.J. Bond. Effects of vitamin supplementation on inflammatory markers and psychological wellbeing among distressed women: A randomized controlled trial. Journal of Integrative Medicine, 2018, 16(5): 322-328.
[14] Chang-quan Ling, Jia Fan, Hong-sheng Lin, Feng Shen, Zhen-ye Xu, Li-zhu Lin, Shu-kui Qin, Wei-ping Zhou, Xiao-feng Zhai, Bai Li, Qing-hui Zhou, on behalf of the Chinese Integrative Therapy of Primary Liver Cancer Working Group. Clinical practice guidelines for the treatment of primary liver cancer with integrative traditional Chinese and Western medicine. Journal of Integrative Medicine, 2018, 16(4): 236-248.
[15] Parunkul Tungsukruthai, Preecha Nootim, Wiwan Worakunphanich, Nareerat Tabtong. Efficacy and safety of herbal steam bath in allergic rhinitis: A randomized controlled trial. Journal of Integrative Medicine, 2018, 16(1): 39-44.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
[1] Wei-xiong Liang. Problems-solving strategies in clinical treatment guideline for traditional Chinese medicine and integrative medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 1-4
[2] Zhao-guo Li. Discussion on English translation of commonly used sentences in traditional Chinese medicine: part one. Journal of Chinese Integrative Medicine, 2008, 6(1): 107-110
[3] Jin-zhou Tian, Jing Shi, Xin-qing Zhang, Qi Bi, Xin Ma, Zhi-liang Wang, Xiao-bin Li, Shu-li Shen, Lin Li, Zhen-yun Wu, Li-yan Fang, Xiao-dong Zhao, Ying-chun Miao, Peng-wen Wang, Ying Ren, Jun-xiang Yin, Yong-yan Wang, Beijing United Study Group on MCI of the Capital Foundation of Medical Developments. An explanation on "guiding principles of clinical research on mild cognitive impairment (protocol)". Journal of Chinese Integrative Medicine, 2008, 6(1): 15-21
[4] Jin-rong Fu. Establishment of multivariate diagnosis and treatment system of modern gynecology of traditional Chinese medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 22-24
[5] Jun Hu, Jian-ping Liu. Non-invasive physical treatments for chronic/recurrent headache. Journal of Chinese Integrative Medicine, 2008, 6(1): 31
[6] Yi-ting He, Qing-lin Zha, Jian-ping Yu, Yong Tan, Cheng Lu, Ai-ping Lv. Principal factor analysis of symptoms of rheumatoid arthritis and their correlations with efficacy of traditional Chinese medicine and Western medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 32-36
[7] Jun Cai, Hua Wang, Sheng Zhou, Bin Wu, Hua-rong Song, Zheng-rong Xuan. Effect of Sijunzi Decoction and enteral nutrition on T-cell subsets and nutritional status in patients with gastric cancer after operation: A randomized controlled trial. Journal of Chinese Integrative Medicine, 2008, 6(1): 37-40
[8] Dong Yang, Yong-ping Du, Qing Shen, Wei Chen, Yan Yu, Guang-lei Chen. Expression of alpha-smooth muscle actin in renal tubulointerstitium in patients with kidney collateral stasis. Journal of Chinese Integrative Medicine, 2008, 6(1): 41-44
[9] Xue-mei Liu, Qi-fu Huang, Yun-ling Zhang, Jin-li Lou, Hong-sheng Liu, Hong Zheng. Effects of Tribulus terrestris L. saponion on apoptosis of cortical neurons induced by hypoxia-reoxygenation in rats. Journal of Chinese Integrative Medicine, 2008, 6(1): 45-50
[10] Zhi-chun Jin. Problems in establishing clinical guideline for integrated traditional Chinese and Western medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 5-8
Journal of Integrative Medicine, ISSN: 2095-4964 CN 31-2083/R
Copyright © Journal of Integrative Medicine
Powered by Beijing Magtech Co. Ltd
沪公网安备31010602003416号      沪ICP备18017633号-3